Sun Pharma board will meet later this week to consider internal restructuring of the business and to announce first quarter results.
The Mumbai-headquartered firm said in a filing to the BSE today that its board meeting on August 10 “would consider the internal restructuring of the business of the company with effect from March 31, 2012’’.
The board will also announce the financial results for the first quarter ended June 30, 2012.
It would also consider declaration of interim dividend of Rs 4.25 per share of Re 1 each on equity shares of the company for the year ended March 31, 2012, the filing said.
Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade, up 1.55 per cent from its previous close.